نتائج البحث - "Böck, Hans-Peter"

1

دورية أكاديمية

Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6): results from a randomised, phase 3 trial

المؤلفون: Mai, Elias K, Goldschmidt, Hartmut, Miah, Kaya, Bertsch, Uta, Besemer, Britta, Hänel, Mathias, Krzykalla, Julia, Fenk, Roland, Schlenzka, Jana, Munder, Markus, Dürig, Jan, Blau, Igor W, Huhn, Stefanie, Hose, Dirk, Jauch, Anna, Kunz, Christina, Mann, Christoph, Weinhold, Niels, Scheid, Christof, Schroers, Roland, von Metzler, Ivana, Schieferdecker, Aneta, Thomalla, Jörg, Reimer, Peter, Mahlberg, Rolf, Graeven, Ullrich, Kremers, Stephan, Martens, Uwe M, Kunz, Christian, Hensel, Manfred, Benner, Axel, Seidel-Glätzer, Andrea, Weisel, Katja C, Raab, Marc S, Salwender, Hans J, Adrian, Nicole, Bernhard, Helga, Böck, Hans-Peter, Bolling, Claus, Dingeldein, Gerrit, Emde, Till-Oliver, Ferstl, Barbara, Fietz, Thomas, Fronhoffs, Stefan, Fuhrmann, Stephan, Fuxius, Stefan, Geer, Thomas, Görner, Martin, Guenther, Barbara, Hartmann, Frank

المساهمون: Bristol-Myers Squibb Company, Chugai Pharmaceuticals Co Ltd

المصدر: The Lancet Haematology ; volume 11, issue 2, page e101-e113 ; ISSN 2352-3026

مصطلحات موضوعية: Hematology

الإتاحة: https://doi.org/10.1016/s2352-3026Test(23)00366-6
https://api.elsevier.com/content/article/PII:S2352302623003666?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2352302623003666?httpAccept=text/plainTest

View record in BASE

2

دورية أكاديمية

Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial

المؤلفون: Rummel, Mathias, Kaiser, Ulrich, Balser, Christina, Stauch, Martina, Brugger, Wolfram, Welslau, Manfred, Niederle, Norbert, Losem, Christoph, Boeck, Hans-Peter, Weidmann, Eckhart, von Gruenhagen, Ulrich, Mueller, Lothar, Sandherr, Michael, Hahn, Lars, Vereshchagina, Julia, Kauff, Frank, Blau, Wolfgang, Hinke, Axel, Barth, Juergen

المصدر: The Lancet Oncology ; volume 17, issue 1, page 57-66 ; ISSN 1470-2045

الإتاحة: https://doi.org/10.1016/s1470-2045Test(15)00447-7
https://api.elsevier.com/content/article/PII:S1470204515004477?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1470204515004477?httpAccept=text/plainTest

View record in BASE

3

دورية أكاديمية

Prospective, Double-Blind, Placebo-Controlled, Multicenter, Randomized Phase III Study with Orally Administered Budesonide for Prevention of Irinotecan (CPT-11)-Induced Diarrhea in Patients with Advanced Colorectal Cancer

المؤلفون: Karthaus, M., Ballo, Harald, Abenhardt, Wolgang, Steinmetz, Tilmann, Geer, Thomas, Schimke, Jörg, Braumann, Dietrich, Behrens, Rüdiger, Behringer, Dirk, Kindler, Manfred, Messmann, Helmut, Boeck, Hans-Peter, Greinwald, Roland, Kleeberg, Ulrich

المصدر: Oncology ; volume 68, issue 4-6, page 326-332 ; ISSN 0030-2414 1423-0232

مصطلحات موضوعية: Cancer Research, Oncology, General Medicine

الإتاحة: https://doi.org/10.1159/000086971Test
https://www.karger.com/Article/Pdf/86971Test

View record in BASE

4

دورية

Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG)

المؤلفون: Forstpointner, Roswitha, Unterhalt, Michael, Dreyling, Martin, Böck, Hans-Peter, Repp, Roland, Wandt, Hannes, Pott, Christiane, Seymour, John F., Metzner, Bernd, Hänel, Annette, Lehmann, Tanja, Hartmann, Frank, Einsele, Hermann, Hiddemann, Wolfgang

المصدر: Blood; December 2006, Vol. 108 Issue: 13 p4003-4008, 6p

النص الكامل

5

دورية

The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group

المؤلفون: Forstpointner, Roswitha, Dreyling, Martin, Repp, Roland, Hermann, Sandra, Hänel, Annette, Metzner, Bernd, Pott, Christiane, Hartmann, Frank, Rothmann, Frank, Rohrberg, Robert, Böck, Hans-Peter, Wandt, Hannes, Unterhalt, Michael, Hiddemann, Wolfgang

المصدر: Blood; November 2004, Vol. 104 Issue: 10 p3064-3071, 8p

النص الكامل

6

دورية

Bendamustine Plus Rituximab Versus Fludarabine Plus Rituximab in Patients with Relapsed Follicular, Indolent, or Mantle Cell Lymphomas – 8-Year Follow-up Results of the Randomized Phase III Study NHL 2-2003 on Behalf of the StiL (Study Group Indolent Lymphomas, Germany)

المؤلفون: Rummel, Mathias J., Balser, Christina, Kaiser, Ulrich, Böck, Hans Peter, Stauch, Martina Beate, Heider, Andrea, Welslau, Manfred, Losem, Christoph, Weidmann, Eckhart, Blau, Wolfgang, Burchardt, Alexander, Barth, Jürgen, Kauff, Frank, Hinke, Axel, Brugger, Wolfram

المصدر: Blood; December 2014, Vol. 124 Issue: 21 p145-145, 1p

النص الكامل

7

دورية

Bendamustine Plus Rituximab (B-R) Versus CHOP Plus Rituximab (CHOP-R) As First-Line Treatment in Patients with Indolent and Mantle Cell Lymphomas (MCL) – 7 Year Updated Results from the StiL NHL1 Study

المصدر: Blood; December 2014, Vol. 124 Issue: 21 p4407-4407, 1p

النص الكامل

8

دورية

Rituximab Maintenance Prolongs Response Duration after Salvage Therapy with R-FCM in Patients with Relapsed Follicular Lymphomas and Mantle Cell Lymphomas: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG).

المؤلفون: Hiddemann, Wolfgang, Forstpointner, Roswitha, Dreyling, Martin, Gramatzki, Martin, Böck, Hans-Peter, Hänel, Mathias, Seymour, John, Planker, Manfred, Dührsen, Ulrich, Wilms, Klaus, Clemens, Martin, Ludwig, Wolf-Dieter, Wandt, Hannes, Pasold, Rita, Unterhalt, Michael

المصدر: Blood; November 2005, Vol. 106 Issue: 11 p920-920, 1p

النص الكامل

9

Fehlertolerante numerische Steuerung

المؤلفون: Bock, Hans-Peter

المساهمون: Verl, Alexander

الإتاحة: http://nbn-resolving.de/urn:nbn:de:bsz:93-opus-101203Test

View record in Europeana

10

Fehlertolerante numerische Steuerung

المؤلفون: Verl, Alexander, Bock, Hans-Peter

الوصول الحر: https://www.europeana.eu/item/2048441/item_ILDKGUUA5TMRW5PXLPHIEIMVM3ACNLFA?utm_source=api&utm_medium=api&utm_campaign=YuvuWBeCaTest

View record in Europeana

تنقيح النتائج